Use of COVID‐19 convalescent plasma in low‐ and middle‐income countries: a call for ethical principles and the assurance of quality and safety

Autor: W. Martin Smid, Thierry Burnouf, Daniel Somuah, Jay S. Epstein, Silvano Wendel

Publikováno v: Vox Sanguinis

Most high‐income countries are aggressively engaged in the collection and research evaluation of convalescent plasma as a specific passive immunotherapy for treatment of COVID‐19. Preliminary clinical data fully support such initiatives. Outbreak

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7fba0580883021510206d5e828dbfe

Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: Single-center results of stepwise escalation of immunosuppression

Autor: Coen A. Stegeman, Anoek A. E. de Joode, W. Martin Smid, Jan-Stephan F. Sanders

Publikováno v: Journal of Clinical Apheresis. 29:266-272

Objective: We evaluated 26 patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) with progressive disease despite treatment with cyclophosphamide and steroids treated with additional plasmapheresis and compared outc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::550c2ed2feef1c8d7c299e421b228227
https://doi.org/10.1002/jca.21318

Platelet binding and phagocytosis by macrophages

Autor: Bahram A Badlou, Jan-Willem N. Akkerman, Ya Ping Wu, W Martin Smid

Publikováno v: Transfusion, 46(8), 1432-43. Wiley

BACKGROUND: Earlier it was reported that metabolic arrest followed by incubation at 4 degrees C reduces the platelet (PLT) storage defect. Here it is reported that this treatment also reduces binding and phagocytosis by macrophages.STUDY DESIGN AND M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45e9b0a28829125650a6d424916e701
https://doi.org/10.1111/j.1537-2995.2006.00913.x

Augmented Procoagulant Activity in Cancer Patients, Treated with Recombinant Interferon-γ in Addition to Recombinant Tumor Necrosis Factor-α and Melphalan

Autor: Robert J. van Ginkel, W. Martin Smid, Jan van der Meer, Heimen Schraffordt Koops, Andre B. Mulder, JH Zwaveling, Armand R. J. Girbes, JK Maring

Publikováno v: Mulder, A B, Zwaveling, J H, Smid, W M, Maring, J K, Van Ginkel, R J, Girbes, A R J, Koops, H S & Van Der Meer, J 1996, ' Augmented procoagulant activity in cancer patients, treated with recombinant interferon-γ in addition to recombinant tumor necrosis factor-α and melphalan ', Thrombosis and Haemostasis, vol. 76, no. 6, pp. 897-901 .
Thrombosis and Haemostasis, 76(6), 897-901. Schattauer GmbH

Several investigators have reported that interferon-gamma (IFN gamma) can alter tumor necrosis factor alpha induced effects in vitro. We assessed in vivo effects of recombinant interferon-gamma (rIFN gamma) on recombinant tumor necrosis factor-alpha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a1528d81a6a719f30aeed5bcc4c204
https://doi.org/10.1055/s-0038-1650683

Lymphocyte subset abnormalities in multitransfused HIV-negative haemophilia A patients are not due to chronic hepatitis C virus infection

Autor: Karina Meijer, Meer, J., Jw, Smit, Spj, Verspiek, Eb, Haagsma, W Martin Smid

Publikováno v: University of Groningen

Several abnormalities of immune parameters have been described in HIV-negative haemophiliacs, including changes in numbers of T4 and T8 cells, T4/T8 ratio and numbers of activated T cells. To assess the contribution of hepatitis C to these abnormalit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::90a753754555a7cfdd8c0b3c1d98f1cd
https://pubmed.ncbi.nlm.nih.gov/10886199